KoBioLabs, Inc (KOSDAQ:348150)

KoBioLabs Statistics

Total Valuation

KoBioLabs has a market cap or net worth of KRW 103.50 billion. The enterprise value is 87.13 billion.

Market Cap	103.50B
Enterprise Value	87.13B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KoBioLabs has 19.42 million shares outstanding. The number of shares has increased by 1.15% in one year.

Current Share Class	19.42M
Shares Outstanding	19.42M
Shares Change (YoY)	+1.15%
Shares Change (QoQ)	-39.26%
Owned by Insiders (%)	29.87%
Owned by Institutions (%)	0.14%
Float	13.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.49
PB Ratio	2.10
P/TBV Ratio	3.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.77
EV / Sales	1.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.33

Financial Position

The company has a current ratio of 4.50, with a Debt / Equity ratio of 0.28.

Current Ratio	4.50
Quick Ratio	3.87
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	-2.26
Interest Coverage	-18.84

Financial Efficiency

Return on equity (ROE) is -13.31% and return on invested capital (ROIC) is -8.93%.

Return on Equity (ROE)	-13.31%
Return on Assets (ROA)	-6.24%
Return on Invested Capital (ROIC)	-8.93%
Return on Capital Employed (ROCE)	-12.39%
Weighted Average Cost of Capital (WACC)	5.76%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.72
Inventory Turnover	3.59

Taxes

In the past 12 months, KoBioLabs has paid 27.13 million in taxes.

Income Tax	27.13M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.34
52-Week Price Change	n/a
50-Day Moving Average	5,257.20
200-Day Moving Average	5,468.90
Relative Strength Index (RSI)	47.02
Average Volume (20 Days)	286,632

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KoBioLabs had revenue of KRW 69.29 billion and -6.33 billion in losses. Loss per share was -326.00.

Revenue	69.29B
Gross Profit	51.03B
Operating Income	-9.65B
Pretax Income	-6.94B
Net Income	-6.33B
EBITDA	-6.87B
EBIT	-9.65B
Loss Per Share	-326.00

Balance Sheet

The company has 47.10 billion in cash and 13.77 billion in debt, with a net cash position of 33.33 billion or 1,716.44 per share.

Cash & Cash Equivalents	47.10B
Total Debt	13.77B
Net Cash	33.33B
Net Cash Per Share	1,716.44
Equity (Book Value)	49.27B
Book Value Per Share	1,660.92
Working Capital	46.60B

Cash Flow

In the last 12 months, operating cash flow was -5.78 billion and capital expenditures -296.78 million, giving a free cash flow of -6.08 billion.

Operating Cash Flow	-5.78B
Capital Expenditures	-296.78M
Depreciation & Amortization	2.78B
Net Borrowing	-3.50B
Free Cash Flow	-6.08B
FCF Per Share	-313.15

Margins

Gross margin is 73.64%, with operating and profit margins of -13.93% and -9.14%.

Gross Margin	73.64%
Operating Margin	-13.93%
Pretax Margin	-10.02%
Profit Margin	-9.14%
EBITDA Margin	-9.92%
EBIT Margin	-13.93%
FCF Margin	n/a

Dividends & Yields

KoBioLabs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.15%
Shareholder Yield	-1.15%
Earnings Yield	-6.12%
FCF Yield	-5.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KoBioLabs has an Altman Z-Score of -0.21 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.21
Piotroski F-Score	4